StageSeries D | Alive
Last Raised$100M | 2 yrs ago
About Lark Health
Lark Health is a virtual chronic disease management and prevention platform. Lark helps people stay healthy and in control of their conditions, such as Diabetes, Prediabetes, Cardiovascular Disease, and Anxiety from the comfort of their homes.
Lark Health's Product Videos
ESPs containing Lark Health
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
Virtual care became more heavily utilized amid the Covid-19 pandemic, and diabetic patients have benefitted from this service. Many of the major telehealth platforms have established diabetes-specific virtual care programs. Even major retailers have thrown their hats into the ring. Beyond these corporations, there are several companies garnering attention.
Lark Health named as Highflier among 10 other companies, including Vida Health, Virta Health, and Wysa.
Compete with Lark Health?
Ensure that your company and products are accurately represented on our platform.
Lark Health's Products & Differentiators
Virtual Care Platform
Lark is a personalized digital health coaching platform that leverages conversational AI, Cognitive Behavioral Therapy (CBT), and platform-integrated devices to provide broadly accessible, scalable, and cost-efficient coaching programs for the prevention and management of chronic disease. Lark’s smartphone-based application of conversational AI provides access to 24/7 coaching and support that drives lasting member behavior change and clinically significant outcomes.
Research containing Lark Health
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Lark Health in 9 CB Insights research briefs, most recently on Dec 12, 2022.
Feb 16, 2022The 130+ AI startups reinventing healthcare
Expert Collections containing Lark Health
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Lark Health is included in 10 Expert Collections, including Digital Health.
Companies developing and enabling evidence-based, software-driven therapeutic interventions to prevent, manage, or treat a medical disorder or disease. (*Scope follows the Digital Therapeutics Alliance definition)
Wearable computing is broadly defined as companies developing devices worn or placed on the body that are equipped with technology, which can range from wearable medical devices to AR/VR headsets to GPS pet collars.
Digital Health 150
2019's cohort of the most promising digital health startups transforming the healthcare industry
Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.
Lark Health Patents
Lark Health has filed 6 patents.
Health informatics, Telehealth, Human proteins, Electronic health records, S/T domain
Health informatics, Telehealth, Human proteins, Electronic health records, S/T domain
Latest Lark Health News
Mar 8, 2023
Lark Health (US) Diabetes Application Segment to Register Strong Growth Thanks to Adoption of Mobile Technology and Digital Health Solutions to Manage Diabetes The digital therapeutics market is gaining momentum due to the rising cases of chronic diseases such as diabetes. In 2021, the diabetes application segment accounted for the largest market share and was expected to grow in the coming years. The reason behind this growth is the effectiveness of digital therapeutics in assisting healthcare providers in assessing patients' health and customizing treatment plans based on their individual therapeutic needs. In addition, with the advent of digital therapeutics, healthcare providers can now offer remote patient care and monitor their patients' progress without physical consultations. The digital therapeutics market is a vital component of the global healthcare industry, and the Asia Pacific region has emerged as a major player in this field. In 2021, the Asia Pacific region captured a significant share of the global therapeutics market, and this trend is expected to continue from 2022 to 2030. According to recent statistics from SkyQuest, an estimated 72 million people in India are over 60 and suffering from a chronic disease. This highlights the urgent need for digital therapeutics to help manage and treat these conditions. Browse summary of the report and Complete Table of Contents (ToC): Patient End-User Segment to Drive Remarkable Sales Growth owing to Rising Demand for Personalized and Convenient Healthcare Solutions The digital therapeutics market has been experiencing significant growth, and the patient end-user segment has played a crucial role in this development. In 2021, the patient end-user segment held the largest market share, and it is projected to continue its dominance from 2022 to 2030. This is due to the increasing adoption of digital therapeutic solutions by patients. Digital therapeutics provide a personalized approach to disease management, where patients can track their symptoms, receive feedback, and learn skills to manage their conditions. These solutions offer several benefits, including improved patient engagement, better health outcomes, and reduced healthcare costs. In 2021, North America emerged as a dominant player in the digital therapeutics market, with a significant global market share. Such significant growth can be attributed to several factors that have fueled the region's adoption of digital health products. With the advent of modern technologies such as smartphones, wearable devices, and telemedicine, patients and healthcare providers are increasingly turning to digital tools to improve patient outcomes and enhance the quality of care. Healthcare systems in the region are increasingly focused on improving the quality of life for patients, and this has led to the development of policies that encourage the use of digital tools for tracking, monitoring, and diagnostics. SkyQuest has conducted an extensive report on the digital therapeutics market, which offers a comprehensive overview of the industry's current and future technical and financial aspects. The report aims to identify emerging trends and market patterns and provides a thorough analysis of the essential dynamics of the global market. The research study also provides new market entrants with a detailed understanding of the current state of the digital therapeutics industry, along with all necessary market statistics. Key Developments in Digital Therapeutics Market South Korean company, LifeSemantics (COPD), has recently launched a digital therapeutics (DTx) product named Redpill Breath, aimed at aiding patients who require pulmonary rehabilitation, particularly those suffering from chronic obstructive pulmonary disease. In addition, the company strives to expand the usage of Redpill Breath across multiple countries, understand the current global trends in DTx technology, and assess the level of demand for the product worldwide. Lapsi Health, a Netherlands-based company that produces audio-driven medical technology and remote healthcare tools, has recently announced the successful closure of an oversubscribed seed round that secured $3.7 million in funding. The company's innovative technology allows physicians to remotely assess, monitor, and treat patients by utilizing a library of clinical stethoscope auscultator sounds, such as breathing sounds in the lungs. Swing Therapeutics, a company focused on developing evidence-based treatments for autoimmune and chronic pain illnesses, has recently shared promising results from a clinical trial. The trial, called REACT-FM, explored Swing's digital therapeutic for managing chronic pain disorder fibromyalgia. According to Swing Therapeutics, their digital therapeutic involving behavioral therapy has shown potential as an effective treatment option for fibromyalgia. Speak to Analyst for your custom requirements: Key Questions Answered in Digital Therapeutics Market Report What are the main drivers and challenges currently affecting the growth of the global market, and how do they impact its development prospects? Can you provide a historical overview of the market's performance and what factors are expected to drive its future growth potential? Who are the key players operating in the global market, and how intense is the competition in the current market environment? What emerging trends are shaping the market, and how are they likely to impact future growth and innovation in the industry? Related Reports in SkyQuest’s Library:
Lark Health Frequently Asked Questions (FAQ)
When was Lark Health founded?
Lark Health was founded in 2011.
Where is Lark Health's headquarters?
Lark Health's headquarters is located at 2570 El Camino Real, Mountain View.
What is Lark Health's latest funding round?
Lark Health's latest funding round is Series D.
How much did Lark Health raise?
Lark Health raised a total of $254.22M.
Who are the investors of Lark Health?
Investors of Lark Health include King River Capital, Franklin Templeton, Olive Tree Capital, IPD Capital, Deerfield Management and 17 more.
Who are Lark Health's competitors?
Competitors of Lark Health include BetterMeal and 8 more.
What products does Lark Health offer?
Lark Health's products include Virtual Care Platform and 4 more.
Who are Lark Health's customers?
Customers of Lark Health include Anthem and Medical Mutual.
Compare Lark Health to Competitors
Vida Health is a virtual care company that combines a human-centric approach with technology to address chronic physical and behavioral health conditions. The company provides personalized digital therapeutic programs combined with real human health coaching & therapy through a mobile & online platform that supports individuals in managing & reversing conditions such as diabetes, hypertension, obesity, depression, anxiety, stress, asthma, & more. The platform integrates individual expert care with machine learning & remote monitoring to deliver lasting behavior change, health outcomes & cost savings.
Omada Health is a digital behavioral medicine company that helps people to change the habits that put them most at risk for serious but largely preventable chronic conditions like heart disease and type 2 diabetes. The company brings behavioral counseling to anyone with an Internet connection, using insights about social networking, gaming, and behavioral science to motivate changes in lifestyle and deliver clinically-meaningful results.
Virta Health develops a clinically-proven treatment to safely and sustainably reverse type 2 diabetes and other chronic metabolic diseases without the use of medications or surgery.
DayTwo provides personalized nutrition and insights that allows users to live healthier and maintain normal blood sugar levels. The company does this by studying an individual's metrics and gut microbiome. Microbiomes have a big impact on health, and DayTwo translates gut bacteria into personalized insights.
Heartbeat provides virtual-first cardiology, delivering clinical services, including same-day diagnostic reads, televisits, and heart care programs for patients with atrial fibrillation, vascular diseases, and heart failure. It was founded in 2017 and is based in New York, New York.
WellDoc is a healthcare behavioral science and technology company that focuses on simplifying the way chronic diseases are managed through a collaborative approach that breaks down the barriers of engagement and adherence by providing patients and healthcare providers with real-time information. WellDoc has developed a technology-based solution designed to help people with chronic diseases better manage conditions. The flagship product, DiabetesManager, provides a system for patients and health care providers to coordinate diabetes care, propel self-management and achieve long-term adherence.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.